METTL14 and hepatocellular carcinoma: Moreover, the inhibition of metastasis was reversed by miR-126 inhibitor in METTL14-overexpressing HCC cells, indicating the significance of miR-126 as a downstream target of METTL14 to inhibit metastatic HCC.